Jupiter Neurosciences
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1001 N US Highway 1 Ste 504, Jupiter, Fl...Phone Number
(561) 406-6154Website
www.jupiterneurosciences.comRevenue
<$5 MillionStock Symbol
JUNSIndustry
About Jupiter Neurosciences
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company headquartered in Jupiter, Florida, focused on treating neuroinflammation and central nervous system disorders. Its lead product, JOTROL, is a proprietary, enhanced-bioavailability resveratrol formulation currently in Phase IIa trials for Parkinson's disease, with additional programs targeting Alzheimer's disease, mucopolysaccharidosis type I, Friedreich's Ataxia, and MELAS. The company also markets consumer longevity products under its Nugevia brand and recently licensed a novel MDMA-based therapeutic candidate for neuropsychiatric disorders such as PTSD.Explore more
Jupiter Neurosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Jupiter Neurosciences
Compare insights from companies similar to Jupiter Neurosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jupiter Neurosciences Tech Stack
A closer look at the technologies used by Jupiter Neurosciences
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Jupiter Neurosciences
Sign Up For FreeTo access detailed company insights
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company headquartered in Jupiter, Florida, focused on treating neuroinflammation and central nervous system disorders. Its lead product, JOTROL, is a proprietary, enhanced-bioavailability resveratrol formulation currently in Phase IIa trials for Parkinson's disease, with additional prog... Read More
